Selectis Health (GBCS) Depreciation & Amortization - Total (2013 - 2025)

Selectis Health (GBCS) has 13 years of Depreciation & Amortization - Total data on file, last reported at $364699.0 in Q3 2025.

• Quarterly Depreciation & Amortization - Total fell 2.52% year-over-year to $364699.0 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $1.1 million (down 9.67% YoY) and the FY2023 annual result came in at $1.7 million, down 7.06% from the prior year.
• Depreciation & Amortization - Total improved to $364699.0 in Q3 2025 per GBCS's latest filing, from $362742.0 in the prior quarter.
• The five-year high for Depreciation & Amortization - Total was $1.7 million in Q1 2021, with the low at -$447070.0 in Q3 2021.
• Average Depreciation & Amortization - Total over 5 years is $440593.9, with a median of $430754.0 recorded in 2023.
• The widest YoY moves for Depreciation & Amortization - Total: up 366.0% in 2021, down 215.29% in 2021.
• Selectis Health's Depreciation & Amortization - Total stood at $447070.0 in 2021, then retreated by 0.64% to $444195.0 in 2022, then declined by 3.03% to $430754.0 in 2023, then dropped by 13.15% to $374118.0 in 2024, then fell by 2.52% to $364699.0 in 2025.
• Business Quant data shows GBCS's Depreciation & Amortization - Total at $364699.0 in Q3 2025, $362742.0 in Q2 2025, and $363020.0 in Q1 2025.